Mirati Therapeutics aims to price public offering of its common shares

Offering to be conducted by Citigroup, Jefferies and Leerink Partners

By Devika Patel

Knoxville, Tenn., Jan. 28 – Mirati Therapeutics, Inc. said it will conduct a public sale of common shares with a 30-day, 15% greenshoe.

Citigroup, Jefferies and Leerink Partners are the bookrunning managers.

The targeted oncology company is based in San Diego.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.